MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- Compare Company
- International - pharmaceuticals
- FDC - TEVA PHARMA (Israel)
FDC vs TEVA PHARMA (Israel) - Comparison Results
TEVA PHARMA (Israel)
Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
Financials
 FDC  TEVA PHARMA |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| FDC Mar-18 |
TEVA PHARMA Dec-13 |
FDC/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 319 | 3,088 | - | |
| Low | Rs | 164 | 2,683 | - | |
| Sales per share (Unadj.) | Rs | 61.6 | 1,772.2 | - | |
| Earnings per share (Unadj.) | Rs | 9.9 | 110.7 | - | |
| Cash flow per share (Unadj.) | Rs | 12.0 | 254.0 | - | |
| Dividends per share (Unadj.) | Rs | 0 | 96.91 | - | |
| Dividend yield (eoy) | % | 0 | 3.4 | 0.0% | |
| Book value per share (Unadj.) | Rs | 73.2 | 1,968.6 | - | |
| Shares outstanding (eoy) | m | 174.40 | 848.00 | - | |
| Bonus/Rights/Conversions | BB | - | - | ||
| Price / Sales ratio | x | 3.9 | 1.6 | 240.6% | |
| Avg P/E ratio | x | 24.3 | 26.1 | 93.1% | |
| P/CF ratio (eoy) | x | 20.2 | 11.4 | 177.7% | |
| Price / Book Value ratio | x | 3.3 | 1.5 | 225.2% | |
| Dividend payout | % | 0 | 87.5 | 0.0% | |
| Avg Mkt Cap | Rs m | 42,118 | 2,446,667 | 1.7% | |
| No. of employees | `000 | 5.5 | 44.9 | 12.3% | |
| Total wages/salary | Rs m | 2,167 | 0 | - | |
| Avg. sales/employee | Rs Th | 1,943.7 | 33,437.1 | 5.8% | |
| Avg. wages/employee | Rs Th | 391.7 | 0 | - | |
| Avg. net profit/employee | Rs Th | 313.7 | 2,088.8 | 15.0% | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Net Sales | Rs m | 10,751 | 1,502,830 | 0.7% | |
| Other income | Rs m | 510 | 0 | - | |
| Total revenues | Rs m | 11,260 | 1,502,830 | 0.7% | |
| Gross profit | Rs m | 2,267 | 411,551 | 0.6% | |
| Depreciation | Rs m | 351 | 121,475 | 0.3% | |
| Interest | Rs m | 14 | 29,518 | 0.0% | |
| Profit before tax | Rs m | 2,411 | 260,558 | 0.9% | |
| Minority Interest | Rs m | -5 | 1,184 | -0.4% | |
| Prior Period Items | Rs m | 0 | 0 | - | |
| Extraordinary Inc (Exp) | Rs m | 0 | -171,042 | 0.0% | |
| Tax | Rs m | 671 | -3,181 | -21.1% | |
| Profit after tax | Rs m | 1,735 | 93,881 | 1.8% | |
| Gross profit margin | % | 21.1 | 27.4 | 77.0% | |
| Effective tax rate | % | 27.8 | -1.2 | -2,280.1% | |
| Net profit margin | % | 16.1 | 6.2 | 258.4% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Current assets | Rs m | 7,213 | 1,015,006 | 0.7% | |
| Current liabilities | Rs m | 2,104 | 885,171 | 0.2% | |
| Net working cap to sales | % | 47.5 | 8.6 | 550.0% | |
| Current ratio | x | 3.4 | 1.1 | 299.0% | |
| Inventory Days | Days | 54 | 91 | 60.0% | |
| Debtors Days | Days | 28 | 96 | 28.9% | |
| Net fixed assets | Rs m | 6,865 | 490,857 | 1.4% | |
| Share capital | Rs m | 175 | 3,699 | 4.7% | |
| Net worth | Rs m | 12,761 | 1,669,359 | 0.8% | |
| Long term debt | Rs m | 6 | 768,430 | 0.0% | |
| Total assets | Rs m | 15,041 | 3,434,448 | 0.4% | |
| Interest coverage | x | 173.2 | 9.8 | 1,762.7% | |
| Debt to equity ratio | x | 0 | 0.5 | 0.1% | |
| Sales to assets ratio | x | 0.7 | 0.4 | 163.3% | |
| Return on assets | % | 11.6 | 3.6 | 323.7% | |
| Return on equity | % | 13.6 | 5.6 | 241.8% | |
| Return on capital | % | 19.0 | 4.9 | 384.4% | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | 1,498 | 239,473 | 0.6% | |
| From Investments | Rs m | 201 | -84,855 | -0.2% | |
| From Financial Activity | Rs m | -1,694 | -287,264 | 0.6% | |
| Net Cashflow | Rs m | 10 | -132,646 | -0.0% | |
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 73.98 Rs / USD
Compare FDC With: MYLAN (US) ADCOCK INGRAM (S. Africa) ACTAVIS (US)
Compare FDC With: ORCHID PHARMA J.B.CHEMICALS DIVIS LABORATORIES PIRAMAL ENTERPRISES SHASUN PHARMA
Today's Market
4 Reasons Why Sensex Surged 750 Points Today(Closing)
Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.
Related Views On News
FDC LTD. Announces Quarterly Results (3QFY20); Net Profit Up 67.7% (Quarterly Result Update)
Feb 10, 2020 | Updated on Feb 10, 2020For the quarter ended December 2019, FDC LTD. has posted a net profit of Rs 733 m (up 67.7% YoY). Sales on the other hand came in at Rs 3 bn (up 26.0% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.
FDC LTD. Announces Quarterly Results (2QFY20); Net Profit Up 45.4% (Quarterly Result Update)
Nov 12, 2019 | Updated on Nov 12, 2019For the quarter ended September 2019, FDC LTD. has posted a net profit of Rs 627 m (up 45.4% YoY). Sales on the other hand came in at Rs 3 bn (up 28.8% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.
FDC LTD. 2017-18 Annual Report Analysis (Annual Result Update)
Mar 28, 2019 | Updated on Mar 28, 2019Here's an analysis of the annual report of FDC LTD. for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of FDC LTD.. Also includes updates on the valuation of FDC LTD..
More Views on NewsMost Popular
It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)
Feb 24, 2021Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
Top 5 Stocks Mutual Funds Bought and Sold in January 2021 (Sector Info)
Feb 16, 2021A look at what India's top equity mutual funds bought and sold in January 2021.
I Would Recommend this Small-cap Stock Over Tesla (Profit Hunter)
Feb 16, 2021Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.
Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)
Feb 25, 2021In this video, I'll show you how to get started on the path to daily trading profits.
More
